Cleidocranial dysplasia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1452OMIM:620099Q74.0
Who is this for?
Show terms as
1Active trials1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Cleidocranial dysplasia (CCD), also known as cleidocranial dysostosis or Marie-Sainton disease, is a rare skeletal disorder characterized by defective development of bones, particularly those formed through membranous ossification. It is caused by mutations in the RUNX2 gene (also called CBFA1), located on chromosome 6p21, which encodes a transcription factor essential for osteoblast differentiation and bone formation. The condition affects multiple body systems, most notably the skeletal system and dentition. The hallmark features of cleidocranial dysplasia include hypoplastic or absent clavicles (collarbones), which allow affected individuals to approximate their shoulders anteriorly in a characteristic fashion. Skull abnormalities are prominent and include delayed closure of cranial sutures and fontanelles, which may remain open throughout life, as well as frontal and parietal bossing, giving the head a broad appearance. Dental abnormalities are a major clinical concern and include delayed eruption or failure of eruption of permanent teeth, supernumerary (extra) teeth, and retention of primary (deciduous) teeth. Other skeletal features may include short stature, a wide pubic symphysis, brachydactyly, scoliosis, and other vertebral anomalies. Hearing loss may also occur due to structural abnormalities of the ossicles or external ear canal. There is currently no cure for cleidocranial dysplasia, and management is multidisciplinary. Dental care is often the most significant aspect of treatment, frequently requiring surgical-orthodontic interventions to remove supernumerary teeth and facilitate eruption of permanent teeth. Orthopedic monitoring is important for skeletal complications. Hearing assessments should be performed regularly. Protective headgear may be recommended in young children with widely open fontanelles. Genetic counseling is advised for affected families, as approximately one-third of cases arise from de novo mutations with no prior family history.

Also known as:

Clinical phenotype terms— hover any for plain English:

Short claviclesHP:0000894
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

1 event
Oct 2021Cleidocranial Dysplasia (CCD): From Genotype to Phenotype and Considerations for Care

Johns Hopkins University

TrialENROLLING BY INVITATION

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Cleidocranial dysplasia.

1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

1 recruitingView all trials with filters →
Other1 trial
Cleidocranial Dysplasia (CCD): From Genotype to Phenotype and Considerations for Care
Enrolling by Invitation
PI: Ilana Ickow, DMD, MS (Johns Hopkins University) · Sites: Baltimore, Maryland

Specialists

1 foundView all specialists →
ID
Ilana Ickow, DMD
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Cleidocranial dysplasia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Cleidocranial dysplasiaForum →

No community posts yet. Be the first to share your experience with Cleidocranial dysplasia.

Start the conversation →

Latest news about Cleidocranial dysplasia

No recent news articles for Cleidocranial dysplasia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Cleidocranial dysplasia

What is Cleidocranial dysplasia?

Cleidocranial dysplasia (CCD), also known as cleidocranial dysostosis or Marie-Sainton disease, is a rare skeletal disorder characterized by defective development of bones, particularly those formed through membranous ossification. It is caused by mutations in the RUNX2 gene (also called CBFA1), located on chromosome 6p21, which encodes a transcription factor essential for osteoblast differentiation and bone formation. The condition affects multiple body systems, most notably the skeletal system and dentition. The hallmark features of cleidocranial dysplasia include hypoplastic or absent clav

How is Cleidocranial dysplasia inherited?

Cleidocranial dysplasia follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Cleidocranial dysplasia typically begin?

Typical onset of Cleidocranial dysplasia is neonatal. Age of onset can vary across affected individuals.

Are there clinical trials for Cleidocranial dysplasia?

Yes — 1 recruiting clinical trial is currently listed for Cleidocranial dysplasia on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Cleidocranial dysplasia?

1 specialists and care centers treating Cleidocranial dysplasia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.